FindTrial
Sign In

Comparision of injection nalbuphine as an adjuvant to injection bupivacaine for pain during post operative period

To assess the efficacy of inj nalbuphine as an adjuvant to intrathecal bupivacaine anaesthetic in endoscopic urological surgeries for prolongation of post operative analgesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053700
Enrollment
60
Registered
2023-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection NALBUPHINE: To cause analgesia, nalbuphine adheres to k receptors. Perioperative analgesia is also improved when administered as an adjuvant to bupivacaine. It is a hybrid whi

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing urological surgeries,duration 1-3 hours.ASA I and II, MPC I and II

Exclusion criteria

Exclusion criteria: Lack of valid consent,ASA grade III and IV, patient with neurological disorder,bleeding disorder,patients on anticoagulants,infection at block site

Design outcomes

Primary

MeasureTime frame
The addition of adjuvant 1.5 mg Nalbuphine prolongs the duration of post operative analgesiaTimepoint: post operative 24 hours—

Secondary

MeasureTime frame
Compare effects on Hemodynamic parameters,onset and suration of sensory and motor block,side effects if anyTimepoint: 2 hours post operative—

Countries

India

Contacts

Public ContactSaiesh Raut Dessai

Datta Medhe Institute of Higher Education And Research

Drsusann02@rediffmail.com9921213404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026